Company Filing History:
Years Active: 2007
Title: Inventor Guo-Ping Wei: Innovating CCR5 Receptor Antagonists
Introduction
Guo-Ping Wei is an accomplished inventor based in San Ramon, California, known for his significant contributions to the field of pharmacology. With one patent to his name, Wei's research focuses on developing novel compounds aimed at addressing CCR5-mediated disorders. His innovative thinking and expertise in this area highlight the importance of modern medicinal chemistry.
Latest Patents
Wei's patent, titled "Substituted quinoline CCR5 receptor antagonists," introduces unique CCR5 receptor antagonists characterized by specific structural formulae. This patent encompasses various forms of these compounds, including enantiomers, diastereomers, salts, and solvates. Moreover, the invention outlines a methodology for treating CCR5-mediated disorders using these novel compounds, illustrating Wei's dedication to advancing therapeutic options in medicine.
Career Highlights
Currently, Guo-Ping Wei is associated with Schering Aktiengesellschaft, a prominent player in the pharmaceutical industry. His role at the company allows him to collaborate with talented researchers and contribute to significant breakthroughs in drug development. Wei's innovative work has positioned him as a valuable contributor to his field.
Collaborations
Wei collaborates with fellow researchers Laura Dunning and Stefan Jaroch, both of whom are esteemed colleagues in the pharmaceutical sector. Together, they work on advancing the understanding and application of CCR5 receptor antagonists, showcasing the power of teamwork in driving scientific progress.
Conclusion
Guo-Ping Wei’s contributions to the field of pharmaceutical innovation exemplify the potential of targeted research in addressing complex medical challenges. With his patent on CCR5 receptor antagonists, Wei is paving the way for new treatments that could significantly impact patient care. His collaborative spirit and dedication to scientific inquiry continue to inspire those in the field of medicinal chemistry.